The Cost Effectiveness of Apligraf ® Treatment of Diabetic Foot Ulcers

Author： Redekop W.K.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.16, 2003-01, pp. : 1171-1183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries

By Ghatnekar O.   Persson U.   Willis M.   Odegaard K.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 767-778

Adis International

Access to resources Recommend Favorite

Optimal Treatment of Infected Diabetic Foot Ulcers

By Edward B. Jude   Philip F. Unsworth  

Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. : 833-850

Adis International

Access to resources Recommend Favorite

Diabetic Foot Ulcers: Practical Treatment Recommendations

By Edmonds Michael  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 913-929

Adis International

Access to resources Recommend Favorite

Filgrastim in the Treatment of Infected Diabetic Foot Ulcers: Retrospective Cost Analysis of a Phase II Randomised Clinical Trial

By Edmonds M.  

Clinical Drug Investigation, Vol. 17, Iss. 4, 1999-04 ,pp. : 275-286

Adis International

Access to resources Recommend Favorite

Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK

By Jansen Jeroen P.  

PharmacoEconomics, Vol. 27, Iss. 12, 2009-12 ,pp. : 1045-1056

Adis International

Access to resources Recommend Favorite